🎉 M&A multiples are live!
Check it out!

Australian Clinical Labs Valuation Multiples

Discover revenue and EBITDA valuation multiples for Australian Clinical Labs and similar public comparables like Bangkok Dusit Medical Services, Sonic Healthcare, and Syngene International.

Australian Clinical Labs Overview

About Australian Clinical Labs

Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.


Founded

2016

HQ

Australia
Employees

4.9K+

Financials

LTM Revenue $463M

LTM EBITDA $127M

EV

$558M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Australian Clinical Labs Financials

Australian Clinical Labs has a last 12-month revenue of $463M and a last 12-month EBITDA of $127M.

In the most recent fiscal year, Australian Clinical Labs achieved revenue of $436M and an EBITDA of $107M.

Australian Clinical Labs expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Australian Clinical Labs valuation multiples based on analyst estimates

Australian Clinical Labs P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $438M $436M XXX XXX XXX
Gross Profit $494M $358M XXX XXX XXX
Gross Margin 113% 82% XXX XXX XXX
EBITDA $110M $107M XXX XXX XXX
EBITDA Margin 25% 25% XXX XXX XXX
Net Profit $113M $22.7M XXX XXX XXX
Net Margin 26% 5% XXX XXX XXX
Net Debt n/a $28.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Australian Clinical Labs Stock Performance

As of March 14, 2025, Australian Clinical Labs's stock price is AUD 3 (or $2).

Australian Clinical Labs has current market cap of AUD 587M (or $371M), and EV of AUD 882M (or $558M).

See Australian Clinical Labs trading valuation data

Australian Clinical Labs Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$558M $371M XXX XXX XXX XXX $0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Australian Clinical Labs Valuation Multiples

As of March 14, 2025, Australian Clinical Labs has market cap of $371M and EV of $558M.

Australian Clinical Labs's trades at 1.2x LTM EV/Revenue multiple, and 4.4x LTM EBITDA.

Analysts estimate Australian Clinical Labs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Australian Clinical Labs and 10K+ public comps

Australian Clinical Labs Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $558M XXX XXX XXX
EV/Revenue 1.2x XXX XXX XXX
EV/EBITDA 4.7x XXX XXX XXX
P/E 19.9x XXX XXX XXX
P/E/Growth 0.9x XXX XXX XXX
EV/FCF 7.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Australian Clinical Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Australian Clinical Labs Valuation Multiples

Australian Clinical Labs's NTM/LTM revenue growth is 6%

Australian Clinical Labs's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Australian Clinical Labs's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Australian Clinical Labs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Australian Clinical Labs and other 10K+ public comps

Australian Clinical Labs Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 0% XXX XXX XXX XXX
EBITDA Margin 26% XXX XXX XXX XXX
EBITDA Growth -3% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 32% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 45% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 75% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Australian Clinical Labs Public Comps

See public comps and valuation multiples for Laboratory Services and Medical Imaging & Diagnostics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Healius XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
Sonic Healthcare XXX XXX XXX XXX XXX XXX
Bangkok Dusit Medical Services XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Australian Clinical Labs M&A and Investment Activity

Australian Clinical Labs acquired  XXX companies to date.

Last acquisition by Australian Clinical Labs was  XXXXXXXX, XXXXX XXXXX XXXXXX . Australian Clinical Labs acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Australian Clinical Labs

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Australian Clinical Labs

When was Australian Clinical Labs founded? Australian Clinical Labs was founded in 2016.
Where is Australian Clinical Labs headquartered? Australian Clinical Labs is headquartered in Australia.
How many employees does Australian Clinical Labs have? As of today, Australian Clinical Labs has 4.9K+ employees.
Who is the CEO of Australian Clinical Labs? Australian Clinical Labs's CEO is Ms. Melinda McGrath.
Is Australian Clinical Labs publicy listed? Yes, Australian Clinical Labs is a public company listed on ASX.
What is the stock symbol of Australian Clinical Labs? Australian Clinical Labs trades under ACL ticker.
When did Australian Clinical Labs go public? Australian Clinical Labs went public in 2021.
Who are competitors of Australian Clinical Labs? Similar companies to Australian Clinical Labs include e.g. Healius, Integral Diagnostics, Sonic Healthcare, Bangkok Dusit Medical Services.
What is the current market cap of Australian Clinical Labs? Australian Clinical Labs's current market cap is $371M
What is the current revenue of Australian Clinical Labs? Australian Clinical Labs's last 12-month revenue is $463M.
What is the current EBITDA of Australian Clinical Labs? Australian Clinical Labs's last 12-month EBITDA is $127M.
What is the current EV/Revenue multiple of Australian Clinical Labs? Current revenue multiple of Australian Clinical Labs is 1.2x.
What is the current EV/EBITDA multiple of Australian Clinical Labs? Current EBITDA multiple of Australian Clinical Labs is 4.4x.
What is the current revenue growth of Australian Clinical Labs? Australian Clinical Labs revenue growth between 2023 and 2024 was 0%.
Is Australian Clinical Labs profitable? Yes, Australian Clinical Labs is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.